Polymorphism of the c‐Ha‐ras‐1 proto‐oncogene in sporadic and familial breast cancer
暂无分享,去创建一个
[1] J. Heighway,et al. Constitutional frequency of rare alleles of c-Ha-ras in breast cancer patients. , 1988, British Journal of Cancer.
[2] M. King,et al. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[3] T. Peto,et al. Statistical methodology in the analysis of relationships between DNA polymorphisms and disease: putative association of Ha-ras-I hypervariable alleles and cancer. , 1988, American journal of human genetics.
[4] F. Wyllie,et al. Ha-ras restriction fragment length polymorphisms in colorectal cancer. , 1988, British Journal of Cancer.
[5] G. Riou,et al. c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles. , 1988, Oncogene research.
[6] S. Kamidono,et al. Lack of correlation between rare Ha‐ras alleles and urothelial cancer in Japan , 1987, International journal of cancer.
[7] A. Viel,et al. Ha-ras-1 restriction fragment length polymorphism and susceptibility to colon adenocarcinoma. , 1987, British Journal of Cancer.
[8] D. Spandidos,et al. Transcriptional enhancer activity in the variable tandem repeat DNA sequence downstream of the human Ha‐ras1 gene , 1987, FEBS letters.
[9] T. Sekiya,et al. Human cancer and cellular oncogenes. , 1987, The Biochemical journal.
[10] R. Kefford,et al. Harvey-ras oncogene restriction fragment alleles in familial melanoma kindreds. , 1986, British Journal of Cancer.
[11] R. Lidereau,et al. High frequency of rare alleles of the human c-Ha-ras-1 proto-oncogene in breast cancer patients. , 1986, Journal of the National Cancer Institute.
[12] H. Lynch,et al. Breast cancer genetics in an oncology clinic: 328 consecutive patients. , 1986, Cancer genetics and cytogenetics.
[13] J. Flint,et al. Ha-ras hypervariable alleles in myelodysplasia , 1986, Nature.
[14] P. Hasleton,et al. Genetic predisposition to human lung cancer. , 1986, British Journal of Cancer.
[15] C. Marshall,et al. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia , 1985, Nature.
[16] H. Lynch,et al. Genetics, biomarkers, and control of breast cancer: a review. , 1984, Cancer genetics and cytogenetics.
[17] M. Barbacid,et al. Spontaneous activation of a human proto-oncogene. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[18] E. Chen,et al. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue , 1983, Nature.
[19] D. Lowy,et al. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus , 1982, Nature.
[20] W. Rutter,et al. Polymorphic DNA region adjacent to the 5' end of the human insulin gene. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[21] P Berg,et al. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. , 1977, Journal of molecular biology.
[22] E. Southern. Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.
[23] D. Gerhard,et al. Evidence against Ha-ras-1 involvement in sporadic and familial melanoma , 1987, Nature.
[24] M. Borrello,et al. HRAS1 proto-oncogene polymorphisms in human malignant melanoma: TaqI defined alleles significantly associated with the disease. , 1987, Oncogene.
[25] D. Parkinson,et al. Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients , 1985, Nature.